NA
TSVT

NewEdge Advisors’s 2seventy bio TSVT Stock Holding History

NewEdge Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-195
Closed -$573 – 4106
2024
Q4 		$573 Hold
195
– – ﹤0.01% 3643
2024
Q3 		$920 Hold
195
– – ﹤0.01% 3526
2024
Q2 		$751 Hold
195
– – ﹤0.01% 3517
2024
Q1 		$1.04K Buy
195
+9
+5% +$42 ﹤0.01% 3489
2023
Q4 		$794 Hold
186
– – ﹤0.01% 3491
2023
Q3 		$729 Hold
186
– – ﹤0.01% 3213
2023
Q2 		$1.88K Hold
186
– – ﹤0.01% 3114
2023
Q1 		$1.9K Hold
186
– – ﹤0.01% 3041
2022
Q4 		$2 Buy
+186
New +$2.62K ﹤0.01% 3963

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

NewEdge Advisors's TSVT Position: Q1 2025 in Review

NewEdge Advisors sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 195 shares — an estimated $573 sold.

NewEdge Advisors first reported a position in TSVT in Q4 2022 and held it in 9 quarters. The position peaked at $1.9K in Q1 2023. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • NewEdge Advisors reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 195 2seventy bio shares in Q1 2025, an estimated $573.
  • NewEdge Advisors first reported a position in 2seventy bio in Q4 2022 and held it in 9 quarters.
  • NewEdge Advisors's 2seventy bio position peaked at $1.9K in Q1 2023.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.